MX2021009726A - Metodos y sistemas para determinar un estado relacionado con el embarazo de un sujeto. - Google Patents

Metodos y sistemas para determinar un estado relacionado con el embarazo de un sujeto.

Info

Publication number
MX2021009726A
MX2021009726A MX2021009726A MX2021009726A MX2021009726A MX 2021009726 A MX2021009726 A MX 2021009726A MX 2021009726 A MX2021009726 A MX 2021009726A MX 2021009726 A MX2021009726 A MX 2021009726A MX 2021009726 A MX2021009726 A MX 2021009726A
Authority
MX
Mexico
Prior art keywords
pregnancy
subject
related state
systems
determining
Prior art date
Application number
MX2021009726A
Other languages
English (en)
Inventor
Maneesh Jain
Eugeni Namsaraev
Morten Rasmussen
Joan Camunas Soler
Farooq Siddiqui
Mitsu Reddy
Original Assignee
Mirvie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mirvie Inc filed Critical Mirvie Inc
Publication of MX2021009726A publication Critical patent/MX2021009726A/es

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/40—Population genetics; Linkage disequilibrium
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Primary Health Care (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Databases & Information Systems (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Bioethics (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Evolutionary Computation (AREA)
  • Software Systems (AREA)
  • Medicinal Chemistry (AREA)
  • Physiology (AREA)
  • Ecology (AREA)

Abstract

La presente descripción proporciona métodos y sistemas dirigidos a la identificación y monitoreo de estados relacionados con el embarazo. Un método para identificar o monitorear la presencia o susceptibilidad de un estado relacionado con el embarazo de un sujeto puede comprender ensayar una muestra biológica libre de células derivada del sujeto para detectar un conjunto de biomarcadores y analizar el conjunto de biomarcadores con un algoritmo entrenado para determinar la presencia o susceptibilidad del estado relacionado con el embarazo.
MX2021009726A 2019-02-14 2020-02-13 Metodos y sistemas para determinar un estado relacionado con el embarazo de un sujeto. MX2021009726A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962805515P 2019-02-14 2019-02-14
US201962890248P 2019-08-22 2019-08-22
US201962926786P 2019-10-28 2019-10-28
PCT/US2020/018172 WO2020168118A1 (en) 2019-02-14 2020-02-13 Methods and systems for determining a pregnancy-related state of a subject

Publications (1)

Publication Number Publication Date
MX2021009726A true MX2021009726A (es) 2021-09-14

Family

ID=72044275

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021009726A MX2021009726A (es) 2019-02-14 2020-02-13 Metodos y sistemas para determinar un estado relacionado con el embarazo de un sujeto.

Country Status (10)

Country Link
US (6) US11208693B2 (es)
EP (1) EP3924972A4 (es)
JP (1) JP2022519897A (es)
CN (1) CN113692624A (es)
AU (1) AU2020221278A1 (es)
CA (1) CA3126990A1 (es)
GB (3) GB2612911B (es)
MX (1) MX2021009726A (es)
SG (1) SG11202108405VA (es)
WO (1) WO2020168118A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2612911B (en) 2019-02-14 2023-11-22 Mirvie Inc Methods and systems for determining a pregnancy-related state of a subject
AU2020286376A1 (en) * 2019-06-03 2021-04-22 Illumina, Inc. Limit of detection based quality control metric
JP2023513470A (ja) 2020-01-30 2023-03-31 プログノミック インコーポレイテッド 肺バイオマーカーおよびそれらの使用方法
WO2022155469A1 (en) * 2021-01-15 2022-07-21 The Trustees Of Columbia University In The City Of New York Using the vaginal metabolome for early prediction of spontaneous preterm birth
CN112662754B (zh) * 2021-01-27 2024-05-14 北京航空航天大学 用于预测小耳畸形发生概率的组合物的应用方法
WO2022173786A1 (en) * 2021-02-10 2022-08-18 Mirvie, Inc. Methods and systems for conducting pregnancy-related clinical trials
US20220328134A1 (en) * 2021-03-31 2022-10-13 PrognomIQ, Inc. Multi-omic assessment
WO2022245773A2 (en) * 2021-05-18 2022-11-24 Mirvie, Inc. Methods and systems for methylation profiling of pregnancy-related states
EP4099335A1 (en) * 2021-06-03 2022-12-07 Tata Consultancy Services Limited System and method for estimation of delivery date of pregnant subject using microbiome data
WO2022256850A1 (en) * 2021-06-04 2022-12-08 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods to assess neonatal health risk and uses thereof
US11664100B2 (en) * 2021-08-17 2023-05-30 Birth Model, Inc. Predicting time to vaginal delivery
US12007397B2 (en) 2021-09-13 2024-06-11 PrognomIQ, Inc. Enhanced detection and quantitation of biomolecules
WO2023081768A1 (en) * 2021-11-04 2023-05-11 Mirvie, Inc. Methods and systems for determining a pregnancy-related state of a subject
WO2023102786A1 (zh) * 2021-12-08 2023-06-15 深圳华大基因股份有限公司 基因标志物在预测孕妇早产风险中的应用
WO2023150726A2 (en) * 2022-02-03 2023-08-10 Nx Prenatal Inc. Three-tiered risk stratification for spontaneous preterm birth
CN114636826B (zh) * 2022-03-02 2022-11-22 广州市妇女儿童医疗中心 Cd177+中性粒细胞在制备新生儿坏死性小肠结肠炎检测产品中的应用
CN114822841A (zh) * 2022-03-24 2022-07-29 川北医学院附属医院 基层适用的严重产后出血风险预测模型及其构建方法
KR20230145829A (ko) * 2022-04-11 2023-10-18 의료법인 성광의료재단 기계학습을 이용한 고위험 임신 질환 예측을 위한 질량 스펙트럼 분석 방법
CN114592074A (zh) * 2022-04-12 2022-06-07 苏州市立医院 一种与胎龄相关的靶标基因组合及其应用
CN116705215B (zh) * 2023-08-04 2023-09-29 南京诺源医疗器械有限公司 一种用于脑室检测的荧光标记系统
CN116904587B (zh) * 2023-09-13 2023-12-05 天津云检医学检验所有限公司 一种用于预测早产的生物标志物组、预测模型及试剂盒
CN117079823B (zh) * 2023-10-17 2024-01-02 北京大学第三医院（北京大学第三临床医学院） 早期预测选择性胎儿生长受限发病风险筛查的系统和方法

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629147A (en) 1992-07-17 1997-05-13 Aprogenex, Inc. Enriching and identifying fetal cells in maternal blood for in situ hybridization
US5432054A (en) 1994-01-31 1995-07-11 Applied Imaging Method for separating rare cells from a population of cells
CA2359816C (en) 1999-01-06 2010-08-03 Genenews Inc. Method for the detection of gene transcripts in blood and uses thereof
US20080009467A1 (en) 2000-05-01 2008-01-10 Accera, Inc. Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolism
US6727066B2 (en) 2000-07-28 2004-04-27 Incyte Corporation Genes expressed in treated human C3A liver cell cultures
US6664056B2 (en) 2000-10-17 2003-12-16 The Chinese University Of Hong Kong Non-invasive prenatal monitoring
AU2003241418A1 (en) 2002-05-10 2003-11-11 Phase-1 Molecular Toxicology, Inc. Liver inflammation predictive genes
WO2004007673A2 (en) 2002-07-12 2004-01-22 The Johns Hopkins University Neuronal gene expression patterns
AU2003272204A1 (en) 2002-07-12 2004-02-02 The Johns Hopkins University Neuronal and retinal gene expression patterns
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
CN101245376A (zh) 2003-01-17 2008-08-20 香港中文大学 作为妊娠相关病症的诊断标志物的循环mRNA
US20060003342A1 (en) 2004-01-15 2006-01-05 Bianchi Diana W Fetal RNA in amniotic fluid to determine gene expression in the developing fetus
CA2574706A1 (en) 2004-07-21 2006-02-23 The Regents Of The University Of California Salivary transcriptome diagnostics
US7713693B1 (en) 2004-09-01 2010-05-11 University Of Louisiana At Monroe Human cancer cell specific gene transcript
US20060166242A1 (en) 2005-01-06 2006-07-27 Mount Sinai Hospital Markers of pre-term labor
EP2612927B1 (en) 2005-03-18 2016-02-03 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
EP2030025A2 (en) 2006-06-07 2009-03-04 Tethys Bioscience, Inc. Markers associated with arteriovascular events and methods of use thereof
WO2008132752A2 (en) 2007-05-01 2008-11-06 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods and kits for predicting cancer metastasis
WO2009009457A1 (en) 2007-07-06 2009-01-15 University Of Louisville Research Foundation, Inc. Alzheimer's disease-specific micro-rna microarray and related methods
EP2612926B1 (en) 2007-08-22 2017-11-29 TrovaGene, Inc. Methods of using mirna for detection of in vivo cell death
US8298768B2 (en) 2007-11-29 2012-10-30 Complete Genomics, Inc. Efficient shotgun sequencing methods
CA2708661A1 (en) 2008-01-27 2009-07-30 Rosetta Genomics Ltd. Methods and compositions for diagnosing complications of pregnancy
WO2009134452A2 (en) 2008-05-01 2009-11-05 Swedish Health Services Preterm delivery diagnostic assay
WO2009143576A1 (en) 2008-05-27 2009-12-03 Adelaide Research & Innovation Pty Ltd Polymorphisms associated with pregnancy complications
WO2009149026A2 (en) 2008-06-01 2009-12-10 Tufts Medical Center, Inc. Genomic approaches to fetal treatment and diagnosis
US7888030B2 (en) 2008-08-21 2011-02-15 King's College London Biomarkers
US20110263441A1 (en) 2008-10-15 2011-10-27 Golub Todd R Compositions, kits, and methods for identification, assessment, prevention, and therapy of hepatic disorders
WO2011029899A1 (en) 2009-09-11 2011-03-17 The Chinese University Of Hong Kong Methods for assessing liver pathologies
WO2011071893A1 (en) 2009-12-08 2011-06-16 Cedars-Sinai Medical Center Diagnostic biomarker to identify women at risk for preterm delivery
CA2798758C (en) 2010-05-18 2019-05-07 Natera, Inc. Methods for non-invasive prenatal ploidy calling
WO2011156734A2 (en) 2010-06-11 2011-12-15 Hitachi Chemical Co., Ltd. Method of characterizing vascular diseases
AU2011275753A1 (en) 2010-07-08 2013-01-10 Pronota N.V. Quiescin Q6 as biomarker for hypertensive disorders of pregnancy
KR20130041961A (ko) 2010-07-23 2013-04-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액에서 질환 또는 상태의 특징을 검출하는 방법
EP2655666A2 (en) * 2010-12-23 2013-10-30 Sequenom, Inc. Fetal genetic variation detection
EP3111937B1 (en) 2011-07-08 2020-06-17 Helmholtz-Zentrum für Infektionsforschung GmbH Medicament for treatment of liver cancer
WO2013022953A2 (en) 2011-08-08 2013-02-14 Eugenia Wang Biomarker for alzheimer's disease and/or mild cognitively impairment, and use thereof
RU2651708C2 (ru) 2011-09-30 2018-04-23 Сомалоджик, Инк. Прогнозирование риска сердечно-сосудистого события и его применение
US9367663B2 (en) 2011-10-06 2016-06-14 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
SG11201505515XA (en) 2012-01-27 2015-09-29 Univ Leland Stanford Junior Methods for profiling and quantitating cell-free rna
US20160289762A1 (en) 2012-01-27 2016-10-06 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiliing and quantitating cell-free rna
EP2825665B1 (en) 2012-03-14 2017-09-06 Ruprecht-Karls-Universität Heidelberg Epigenetic signatures as marker for cardiomyopathies and myocardial insufficiencies
US10054599B2 (en) 2013-03-12 2018-08-21 Agency For Science, Technology And Research (A*Star) Pre-eclampsia biomarkers
WO2014150198A2 (en) 2013-03-15 2014-09-25 Somalogic, Inc. Nonalcoholic fatty liver disease (nafld) and nonalcoholic steatohepatitis (nash) biomarkers and uses thereof
WO2014193999A2 (en) * 2013-05-28 2014-12-04 Caris Science, Inc. Biomarker methods and compositions
CN104673925A (zh) 2015-03-19 2015-06-03 绍兴锐创生物科技有限公司 能检测多种新生儿遗传病的rna探针及基因筛查试剂盒
US20180155787A1 (en) 2015-06-05 2018-06-07 Regulus Therapeutics Inc. Non-alcoholic fatty liver disease biomarkers
US11009512B2 (en) * 2015-09-11 2021-05-18 Universidad De Los Andes In vitro method for identifying a pregnancy related disease
DK3350341T3 (da) 2015-09-14 2021-09-27 Genfit Fremgangsmåder til diagnosticering og evaluering af non-alkoholisk steatohepatitis
WO2017141169A1 (en) * 2016-02-16 2017-08-24 Tata Consultancy Services Limited Method and system for early risk assessment of preterm delivery outcome
EP3426826A4 (en) 2016-03-09 2019-09-04 Molecular Stethoscope, Inc. METHODS AND SYSTEMS FOR DETECTION OF TISSUE STATES
GB2612911B (en) 2019-02-14 2023-11-22 Mirvie Inc Methods and systems for determining a pregnancy-related state of a subject

Also Published As

Publication number Publication date
GB2615975B (en) 2023-11-29
US20220073982A1 (en) 2022-03-10
US11851706B2 (en) 2023-12-26
WO2020168118A1 (en) 2020-08-20
JP2022519897A (ja) 2022-03-25
US11441183B2 (en) 2022-09-13
US11845988B2 (en) 2023-12-19
US20220380846A1 (en) 2022-12-01
US20240117429A1 (en) 2024-04-11
GB2615975A (en) 2023-08-23
US20220380847A1 (en) 2022-12-01
EP3924972A4 (en) 2023-03-29
GB2597379B (en) 2022-12-28
GB2612911B (en) 2023-11-22
CN113692624A (zh) 2021-11-23
GB2612911A (en) 2023-05-17
US20230250477A1 (en) 2023-08-10
GB202216607D0 (en) 2022-12-21
GB2597379A (en) 2022-01-26
GB202308486D0 (en) 2023-07-19
US20210017598A1 (en) 2021-01-21
CA3126990A1 (en) 2020-08-20
GB202111725D0 (en) 2021-09-29
SG11202108405VA (en) 2021-08-30
AU2020221278A1 (en) 2021-08-05
US11208693B2 (en) 2021-12-28
EP3924972A1 (en) 2021-12-22

Similar Documents

Publication Publication Date Title
MX2021009726A (es) Metodos y sistemas para determinar un estado relacionado con el embarazo de un sujeto.
MX2023001781A (es) Metodos y sistemas para determinar un estado relacionado con el embarazo de un sujeto.
MX2016006455A (es) Dispositivo integrado de fuente-pixel activo para el analisis rapido de especimenes biologicos y quimicos.
KR101931420B1 (ko) 세포의 분화 상태의 평가 방법
MX2020004617A (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
MX348392B (es) Sistemas y metodos para diagnostico de la salud.
EA201370085A1 (ru) Новые системы и способы неразрушающего контроля самолетов
MX350533B (es) Biomarcadores de cancer pancreatico y usos de los mismos.
MX2015013596A (es) Metodos, dispositivos y sistemas para analisis de muestras.
WO2019066572A3 (en) Method and device for analyzing target analyte in sample
MX2021008520A (es) Metodos y sistemas para deteccion de analitos.
WO2020003150A3 (en) Image based novelty detection of material samples
BR112022011676A2 (pt) Kit para detectar um analito de interesse em uma pluralidade de amostras líquidas biológicas, método para detectá-lo e /ou quantificá-lo e cartucho para realizar tal método
MX2022009783A (es) Ensayo de proximidad.
MX2020002788A (es) Biomarcadores de preeclampsia y sistemas y metodos relacionados.
SG11201905743PA (en) Abnormality monitoring device, abnormality monitoring method, and program
SG10201705480UA (en) System and method for determining event
MX2019010478A (es) Sistemas y métodos para la detección y cuantificación enzimáticas de a1c.
SG11201811433TA (en) Mmp1 gene transcript for use as marker for diagnosis of ovarian cancer prognosis, and test method
MX2020012713A (es) Metodos, dispositivos y sistemas para cuantificar biomarcadores.
WO2022245773A3 (en) Methods and systems for methylation profiling of pregnancy-related states
MX2017014212A (es) Sistemas y metodos para deteccion y medicion electroquimica de cetona.
BR112012029520A2 (pt) instrumento de diagnóstico e processo de fluxo.
WO2019089858A3 (en) Methods of assessing or monitoring a response to a cell therapy
WO2021119504A3 (en) Materials and methods for monitoring inflammation